Curcumin has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cladribine, Ubrogepant. Patients taking Curcumin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 1
- Moderate
- 1
Major (1)
- Curcumin + Cladribine— Potent BCRP, ENT1, and CNT3 transporter inhibitor may alter cladribine bioavailability, intracellular distribution, and …
Moderate (1)
- Curcumin + Ubrogepant— BCRP and/or P-gp inhibitor that may increase ubrogepant exposure. Dose adjustment recommended.